Characterization of human polymorphic DNA repair methyltransferase

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• O6-methylguanine-DNA methyltransferase (MGMT) is crucial for defending against DNA damage from alkylating agents.
• Significant interindividual variation exists in MGMT activity, partly due to genetic polymorphisms.
• Three human MGMT allelic variants (V1, V2, V3) were previously identified, with V1 and V2 involving amino acid changes.

Purpose of the Study:

• To investigate the in vivo characteristics and functional significance of the V1 and V2 MGMT variants.
• To understand the pharmacogenetic and ecogenetic implications of MGMT gene polymorphism.

Main Methods:

• Assessing cellular sensitivity to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in E. coli and HeLa cells expressing wild-type, V1, or V2 MGMT.
• Quantifying methyltransferase protein levels in cells with different MGMT variants.
• Conducting in vitro translation experiments to evaluate protein production.
• Analyzing kinetic values of purified recombinant wild-type and variant MGMT proteins.

Main Results:

• Cells expressing V1 MGMT showed similar MNNG sensitivity and protein levels to wild-type.
• Cells expressing V2 MGMT exhibited reduced survival and significantly lower protein levels, despite normal mRNA production.
• In vitro studies indicated V2 protein is likely unstable and rapidly degraded in vivo.
• Kinetic analysis of purified proteins supported the instability of the V2 variant.

Conclusions:

• The wild-type and V1 MGMT proteins possess comparable enzymatic and physicochemical properties.
• The V2 MGMT variant results in an unstable protein that is rarely detected in vivo, potentially compromising DNA repair capacity.
• MGMT gene polymorphism significantly influences enzyme stability and function, with implications for DNA repair and carcinogenesis.